Topics
-
Sysmex Selected as a Winner of New Diversity Management Selection 100 for FY2020
-
Posted Our Company Briefing Presentation for Our Stakeholders
-
Posted the 18th Technology Presentation
-
Demo Day: Kansai Life Science Accelerator Program, an accelerator program for Japanese life science startup companies
-
Implementing “Sysmex Gives Back Day”, a Group-wide Social Contribution Activities
-
Our Response to the Coronavirus Disease 2019
Press Releases
-
Sysmex Continues to Evolve Its Hematology Product Portfolio
- Flagship Model XR-Series and Compact 3-part WBC Differential Model XQ-Series to Be Rolled Out Sequentially - (PDF：209KB) - Announcement of Organizational and Personnel Changes (PDF：385KB)
-
Sysmex Presents Academic Report on Creating a Simple Method of Diagnosing Alzheimer’s Disease Using Blood
- Presenting the Most Recent Data at the 15th International Conference on Alzheimer’s & Parkinson’s Diseases (AD/PD 2021) - (PDF：118KB) -
Sysmex Obtains Manufacturing and Marketing Approval for an Influenza A/B Virus Antigen Detection Test Kit
Influenza can be simultaneously measured in a short period of time in the same the novel coronavirus (SARS-CoV-2) antigen sample using the HISCL™-5000/HISCL-800 Automated Immunoassay Systems - h (PDF：170KB) -
Sysmex Receives Approval for a Partial Change to the OncoGuide™ NCC Oncopanel System for Use in Cancer Genome Profiling
- Detection of 10 New Gene Mutations Including MSH6 and PMS2, NTRK3 Gene Fusion and Microsatellite Instability - (PDF：238KB)
